Global burden and health inequality of atrial fibrillation/atrial flutter from 1990 to 2021
Frontiers in Cardiovascular Medicine · 21.05.2025 · 12
DOI: 10.3389/fcvm.2025.1585980 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 21.05.2025. Verfasst von Xia Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology 1, Hebei Provincial Hospital of Chinese Medicine, Shijiazhuang, Hebei, China. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Atrial fibrillation (AF) and atrial flutter (AFL) are the most prevalent tachyarrhythmias worldwide, leading to severe complications such as stroke and heart failure. Despite advancements in diagnosis and management, the global burden of AF/AFL continues to increase, highlighting the urgent need for comprehensive epidemiological research.
Methods
This study analyzed data from the Global Burden of Disease (GBD) 2021 to examine the incidence, prevalence, mortality, and disability-adjusted life years (DALYs) associated with AF/AFL from 1990 to 2021. Age-standardized rates were calculated at global, regional, and country-specific levels. Decomposition and Bayesian age-period-cohort models were used to explore trends and forecast future disease burdens.
Results
In 2021, AF/AFL contributed to 4.48 million new cases globally, with an age-standardized incidence rate (ASIR) of 52.1 per 100,000. The global prevalence reached 52.55 million cases, while the disease caused 338,947 deaths. The global age-standardized DALY rate stood at 101.4 per 100,000. Significant disparities were observed, with higher disease burdens in high Socio-demographic Index (SDI) regions compared to low SDI regions. Between 1990 and 2021, aging and population growth were key drivers of the increased burden, with regional variations associated with economic development and healthcare access. Bayesian projections indicate a gradual rise in incidence and prevalence through 2050, although mortality and DALY rates are expected to decline.
Conclusions
AF/AFL presents a substantial public health challenge, with rising incidence and prevalence primarily driven by demographic changes and enhanced diagnostic capabilities. Addressing health inequalities requires targeted interventions and strengthening healthcare systems. Future strategies should prioritize prevention and equitable access to advanced therapies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology 1, Hebei Provincial Hospital of Chinese Medicine, Shijiazhuang, Hebei, China.
- Department of Child Healthcare, The Fourth Hospital of Shijiazhuang, Gynecology and Obstetrics Hospital Affiliated to Hebei Medical University, Shijiazhuang, Hebei, China.
- Internal Medicine 1, Xinle Hospital of Traditional Chinese Medicine, Shijiazhuang, Hebei, China.
Zitieren
APA
Li, X., Li, Z., He, H., Wang, S., Su, H., & Kang, G. (2025). Global burden and health inequality of atrial fibrillation/atrial flutter from 1990 to 2021. Frontiers in Cardiovascular Medicine, 12. https://doi.org/10.3389/fcvm.2025.1585980
Vancouver
Li X, Li Z, He H, Wang S, Su H, Kang G. Global burden and health inequality of atrial fibrillation/atrial flutter from 1990 to 2021. Frontiers in Cardiovascular Medicine. 2025;12. doi:10.3389/fcvm.2025.1585980
BibTeX
@article{Li2025,
author = {Li, Xia and Li, Zhen and He, Hongtao and Wang, Sizhou and Su, Honglei and Kang, Guobin},
title = {Global burden and health inequality of atrial fibrillation/atrial flutter from 1990 to 2021},
journal = {Frontiers in Cardiovascular Medicine},
year = {2025},
volume = {12},
doi = {10.3389/fcvm.2025.1585980}
}
EUVIMED